258 related articles for article (PubMed ID: 25240975)
1. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model.
van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH
Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975
[TBL] [Abstract][Full Text] [Related]
2. Role of epigenetics in the etiology of germ cell cancer.
Van Der Zwan YG; Stoop H; Rossello F; White SJ; Looijenga LH
Int J Dev Biol; 2013; 57(2-4):299-308. PubMed ID: 23784841
[TBL] [Abstract][Full Text] [Related]
3. Tumor risk in disorders of sex development (DSD).
Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
[TBL] [Abstract][Full Text] [Related]
4. New insight into the aetiology of testicular germ cell tumours.
Huddart R
Eur Urol; 2015 Apr; 67(4):702-3. PubMed ID: 25497430
[No Abstract] [Full Text] [Related]
5. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD).
Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH
Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106
[TBL] [Abstract][Full Text] [Related]
6. The biology of germ cell tumors in disorders of sex development.
Hersmus R; van Bever Y; Wolffenbuttel KP; Biermann K; Cools M; Looijenga LH
Clin Genet; 2017 Feb; 91(2):292-301. PubMed ID: 27716895
[TBL] [Abstract][Full Text] [Related]
7. Tumor risk and clinical follow-up in patients with disorders of sex development.
Cools M; Looijenga LH
Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():519-24. PubMed ID: 22423509
[TBL] [Abstract][Full Text] [Related]
8. Gonadal tumours and DSD.
Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP
Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development.
Jørgensen A; Lindhardt Johansen M; Juul A; Skakkebaek NE; Main KM; Rajpert-De Meyts E
Semin Cell Dev Biol; 2015 Sep; 45():124-37. PubMed ID: 26410164
[TBL] [Abstract][Full Text] [Related]
10. Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology.
Looijenga LHJ; Kao CS; Idrees MT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658757
[TBL] [Abstract][Full Text] [Related]
11. Development of malignant germ cells - the genvironmental hypothesis.
Looijenga LH; Van Agthoven T; Biermann K
Int J Dev Biol; 2013; 57(2-4):241-53. PubMed ID: 23784835
[TBL] [Abstract][Full Text] [Related]
12. Tumor risk in disorders of sex development.
Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH
Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977
[TBL] [Abstract][Full Text] [Related]
13. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
14. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients.
Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K
Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751
[TBL] [Abstract][Full Text] [Related]
15. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy.
Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S
Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272
[TBL] [Abstract][Full Text] [Related]
16. Gonadal malignancy in 13 consecutive collected patients with disorders of sex development (DSD) from Semarang (Indonesia).
Juniarto AZ; Setyawati BA; Miranti IP; Santosa A; Hersmus R; Stoop H; Cools M; Oosterhuis JW; Drop SL; Faradz SM; Looijenga LH
J Clin Pathol; 2013 Mar; 66(3):198-204. PubMed ID: 23268320
[TBL] [Abstract][Full Text] [Related]
17. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD).
Hersmus R; Kalfa N; de Leeuw B; Stoop H; Oosterhuis JW; de Krijger R; Wolffenbuttel KP; Drop SL; Veitia RA; Fellous M; Jaubert F; Looijenga LH
J Pathol; 2008 May; 215(1):31-8. PubMed ID: 18348162
[TBL] [Abstract][Full Text] [Related]
18. Advances in molecular markers of germ cell cancer in patients with disorders of sex development.
van der Zwan YG; Cools M; Looijenga LH
Endocr Dev; 2014; 27():172-84. PubMed ID: 25247654
[TBL] [Abstract][Full Text] [Related]
19. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers.
Cools M; Drop SL; Wolffenbuttel KP; Oosterhuis JW; Looijenga LH
Endocr Rev; 2006 Aug; 27(5):468-84. PubMed ID: 16735607
[TBL] [Abstract][Full Text] [Related]
20. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.
Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW
Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
